Bone marrow protection with amifostine in the treatment of high-risk malignant lymphoma

This publication has 9 references indexed in Scilit:

• Intensive brief chemotherapy with hematopoietic growth factors as hematological support and adjuvant radiotherapy improve the prognosis in aggressive malignant lymphoma
  American Journal of Hematology, 1996
• Amifostine, cisplatin, and vinblastine in metastatic non-small-cell lung cancer: a report of high response rates and prolonged survival.
  Journal of Clinical Oncology, 1996
• Amifostine (WR-2721) Protects Normal Haematopoietic Stem Cells Against Cyclophosphamide Derivatives' Toxicity Without Compromising Their Antileukaemic Effects
  European Journal Of Cancer, 1995
• Protection of Normal Tissue from the Cytotoxic Effects of Chemotherapy and Radiation by Amifostine: Clinical Experiences
  European Journal Of Cancer, 1995
• Amifostine
  Drugs, 1995
• A Predictive Model for Aggressive Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1993
• Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1993
• New Protective Agents for Bone Marrow in Cancer Therapy
  Cancer Investigation, 1991
• Approaches to ablating the myelotoxicity of chemotherapy
  Critical Reviews in Oncology/Hematology, 1987